当前位置: X-MOL 学术J. Am. Acad. Dermatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology
Journal of the American Academy of Dermatology ( IF 12.8 ) Pub Date : 2018-10-05 , DOI: 10.1016/j.jaad.2018.09.052
Sailesh Konda , Joseph Francis , Kiran Motaparthi , Jane M. Grant-Kels

Within the past 2 decades, for-profit financial groups have become increasingly involved in health care. Outlier dermatology practices with high volumes of well-reimbursed procedures are attractive to consolidation backed by private equity. With fewer choices for independent or group private practice, junior dermatologists are increasingly seeking employment without ownership in private equity–backed corporate groups whose primary fiscal responsibility lies with their investors. Medicare's response to corporatization and consolidation has already changed the practice of dermatopathology. Dermatologists should be aware of this history, given the ability of corporations and private equity groups to shape the present and future of our field.



中文翻译:

21世纪美国政策改革背景下临床皮肤病学的未来考虑:公司化和皮肤病学领域私募股权的兴起

在过去的20年中,以营利为目的的金融集团越来越多地参与医疗保健。高额报销程序的异常皮肤病学实践对于以私募股权为后盾的合并很有吸引力。对于独立或团体私人执业的选择越来越少,初级皮肤科医生正越来越多地寻求没有私人股权支持的企业集团的所有权的公司,而企业集团的主要财政责任在于其投资者。Medicare对公司化和合并的反应已经改变了皮肤病理学的实践。鉴于公司和私募股权集团有能力塑造我们这个领域的现在和将来,皮肤科医生应该意识到这一历史。

更新日期:2019-06-20
down
wechat
bug